Skip to main content Skip to main navigation menu Skip to site footer

A patient with acute fatty liver of pregnancy (AFLP) with acute pancreatitis manifestations

  • Megawati Rif'atyyah Nozomi Guntur ,
  • Ulfa Kholili ,


Abstract

Background: Liver disease in pregnancy can be related to the process of pregnancy (liver disease of pregnancy) or not associated with pregnancy (liver disease in pregnancy). Acute fatty liver of pregnancy (AFLP) is a rare but life-threatening cause of jaundice in the third trimester of pregnancy and early postpartum period which in most cases no definitive risk factors are found. In this case report, we report a patient with AFLP with acute pancreatitis manifestations.

Case presentation: A 33-year-old woman referred to the Dr Soetomo General Academic Hospital, Surabaya, Indonesia with diagnosis of day-4 post-section caesarian (SC) accompanied by ileus paralytic, obstructive jaundice hypoalbuminemia hyperbilirubinemia, acalculi cholecystitis, acute kidney injury (AKI) with dd acute on chronic kidney disease (ACKD), suspect pneumonia, and sepsis. Indications for SC were premature rupture of membrane (PROM). The patient initially complained of yellow body and eyes 10 days before delivery with additional complaints including tea-colored urine and brown feces. Chest x-ray results showed infiltrates on the right paracardial suggesting pulmonary inflammation. Abdominal x-rays showed normal result. Abdominal ultrasound results suggested acalculi cholecystitis, however, liver, lien, pancreas, kidney right and left, urinary bladder, uterus, adnexa right and left showed no abnormality. The patient was treated with intravenous fluids, nasogastric insertion for nutrition, analgesics and antibiotics and other symptomatic therapy. The patient was discharged after 20 days of treatment.

Conclusion: This case highlights a potentially fatal complication of AFLP case with acute pancreatitis manifestations and the need of rapid diagnosis and comprehensive management to avoid the complicaton and death.

Keywords: acute fatty liver of pregnancy acute pancreatitis Swansea criteria jaundice liver disease

References

  1. Akbar MIA. Preeclampsia: Biomarkers, Imitators And Clinical Complications: Universitas Airlangga; 2020.
  2. Ridho HR, Akbar MIA, Fatmaningrum W, Santoso B. Correlation between Anemia and Preeclampsia in Universitas Airlangga Hospital in 2017. JUXTA J Ilm Mhs Kedokt Univ Airlangga. 2021;12(2):66. Available from: http://dx.doi.org/10.20473/juxta.v12i22021.66-71
  3. Dyah AA, Rahadina R. Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis. Clin Exp Hepatol. 2021/09/20. 2021;7(3):305–11. Available from: https://pubmed.ncbi.nlm.nih.gov/34712833
  4. Gami N, Singhal S, Puri M, Dhakad A. An approach to diagnosis and management of acute fatty liver of pregnancy. Int J Reprod Contraception, Obstet Gynecol. 2013;104–8. Available from: http://dx.doi.org/10.5455/2320-1770.ijrcog20130221
  5. Dahlan Z, Sudoyo A, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. Textbook of Internal Medicine sixth edition. Jakarta: Universitas Indonesia Publication Center. 2009: 1608-19.
  6. Goel A, Lye Ch’ng C, Eapen CE, Balasubramanian KA, Elias E. Acute Fatty Liver of Pregnancy: Better Understanding of Pathogenesis and Earlier Clinical Recognition Results in Improved Maternal Outcomes. EMJ Hepatol. 2018;72–9. Available from: http://dx.doi.org/10.33590/emjhepatol/10314416
  7. Ko H, Yoshida EM. Acute fatty liver of pregnancy. Can J Gastroenterol. 2006;20(1):25–30. Available from: https://pubmed.ncbi.nlm.nih.gov/16432556
  8. Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013;209(5):456.e1-456.e7. Available from: http://dx.doi.org/10.1016/j.ajog.2013.07.006
  9. Fesenmeier MF, Coppage KH, Lambers DS, Barton JR, Sibai BM. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005;192(5):1416–9. Available from: http://dx.doi.org/10.1016/j.ajog.2004.12.035
  10. Moldenhauer JS, O’Brien JM, Barton JR, Sibai B. Acute fatty liver of pregnancy associated with pancreatitis: A life-threatening complication. Am J Obstet Gynecol. 2004;190(2):502–5. Available from: http://dx.doi.org/10.1016/j.ajog.2003.09.022
  11. Aldika Akbar MI, Mayang Sari I, Aditiawarman, Dachlan EG, Dekker G. Clinical characteristics of acute fatty liver of pregnancy in a tertiary Indonesian hospital. J Matern & Neonatal Med. 2017;32(5):826–32. Available from: http://dx.doi.org/10.1080/14767058.2017.1393067
  12. Dey M, Kumar R, Narula GK, Vadhera A. Acute fatty liver of pregnancy. Med journal, Armed Forces India. 2012/09/15. 2014;70(4):392–3. Available from: https://pubmed.ncbi.nlm.nih.gov/25382919
  13. Ibdah J-A. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol. 2006;12(46):7397–404. Available from: https://pubmed.ncbi.nlm.nih.gov/17167825
  14. Al-Husban N, Al-Kuran O, Al Helou A. Postpartum acute fatty liver of pregnancy: a case report. J Med Case Rep. 2018;12(1):67. Available from: https://pubmed.ncbi.nlm.nih.gov/29855383
  15. Cruciat G, Stamatian F, Puscas M, Cruciat C, Ispasoiu F, Mureşan D. Acute pancreatitis in a pregnant woman with acute fatty liver dystrophy. A case report. J Gastrointestin Liver Dis. 2007;16(2):193-6.
  16. Koff RS. Textbook of gastroenterology. Edited by T. Yamada, D.H. Alpers, C. Owyang, D.W. Powell and F.E. Silverstein, 2,683 pp. Philadelphia: J. B. Lippincott, 1991. $180. Hepatology. 1992;15(3):559–60. Available from: http://dx.doi.org/10.1002/hep.1840150336
  17. Dooley JS, Lok AS, Garcia-Tsao G, Pinzani M. Sherlock’s Diseases of the Liver and Biliary System [Internet]. Wiley; 2018. Available from: http://dx.doi.org/10.1002/9781119237662
  18. Pithawa AK. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: pathophysiology, diagnosis, management. Med J Armed Forces India. 2007;63(2):205. Available from: http://dx.doi.org/10.1016/s0377-1237(07)80085-2
  19. de Oliveira CV, Moreira A, Baima JP, Franzoni L de C, Lima TB, Yamashiro F da S, et al. Acute fatty liver of pregnancy associated with severe acute pancreatitis: A case report. World J Hepatol. 2014;6(7):527–31. Available from: https://pubmed.ncbi.nlm.nih.gov/25068005
  20. Forsmark CE, Swaroop Vege S, Wilcox CM. Acute Pancreatitis. N Engl J Med. 2016;375(20):1972–81. Available from: http://dx.doi.org/10.1056/nejmra1505202
  21. Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27. Available from: https://pubmed.ncbi.nlm.nih.gov/31210778
  22. Wang G, Wen J, Wen P, Wilbur RR, Zhou S-F, Xiao X. The Effect of Somatostatin, Ulinastatin and Salvia miltiorrhiza on Severe Acute Pancreatitis Treatment. Am J Med Sci. 2013;346(5):371–6. Available from: http://dx.doi.org/10.1097/maj.0b013e31827aa2bc
  23. Uhl W, Anghelacopoulos SE, Friess H, Büchler MW. The Role of Octreotide and Somatostatin in Acute and Chronic Pancreatitis. Digestion. 1999;60(Suppl. 2):23–31. Available from: http://dx.doi.org/10.1159/000051477
  24. Li J, Wang R, Tang C. Somatostatin and Octreotide on the Treatment of Acute Pancreatitis - Basic and Clinical Studies for Three Decades. Curr Pharm Des. 2011;17(16):1594–601. Available from: http://dx.doi.org/10.2174/138161211796196936
  25. Omata F, Deshpande G, Tokuda Y, Takahashi O, Ohde S, Carr-Locke DL, et al. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. J Gastroenterol. 2010;45(8):885–95. Available from: http://dx.doi.org/10.1007/s00535-010-0234-4
  26. Gurusamy KS, Koti R, Fusai G, Davidson BR. Somatostatin analogues for pancreatic surgery. Cochrane database Syst Rev. 2013;2013(4):CD008370–CD008370. Available from: https://pubmed.ncbi.nlm.nih.gov/23633353

How to Cite

Nozomi Guntur, M. R. ., & Kholili, U. (2023). A patient with acute fatty liver of pregnancy (AFLP) with acute pancreatitis manifestations. Bali Medical Journal, 12(2), 1538–1542. https://doi.org/10.15562/bmj.v12i2.4288
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Megawati Rif'atyyah Nozomi Guntur
Google Scholar
Pubmed
BMJ Journal

Ulfa Kholili
Google Scholar
Pubmed
BMJ Journal